For instance, robust evidence reported that the pharmacological and genetic inactivation of FAAH not only restored the levels of its endogenous substrate anandamide (N-arachidonoylethanolamine), but it also dramatically ameliorated AD-like symptoms in terms of Aβ accumulation, neuroinflammation and cognitive decline [9,10]. The gene discussed is FAAH; the disease is Alzheimer disease.